Author:
KURT Şeyma,ERİŞGİN Züleyha,TEKELİOĞLU Yavuz,AKMAN Ahmet,TÜREDİ Sibel
Publisher
Celal Bayar Universitesi Saglık Bilimleri Enstitusu Dergisi
Subject
Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management
Reference43 articles.
1. 1. Panetta JC, Sparreboom A, Pui CH, Relling MV, Evans WE. Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells. PLoS Comput Biol 2010; 2;6[12]:e1001019. doi: 10.1371/journal.pcbi.1001019.
2. 2. Chabner B, Wilson W, Supko J. Pharmacology and toxicity of antineoplastic drugs. Editorial: Lichtman MA, Beutler E, Seligsohn U, Kipps TJ, Kaushansky K. In Williams Hematology. 7th Edition. Mc Graw Hill Company, United States. 2007; 249-51.
3. 3. Van Ede AE, Laan RF, Blom HJ, De Abreu RA, Van De Putte LB. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Seminars in Arthritis and Rheumatism 1998; 27:277-292.
4. 4. Jollivet J., Cowan K., Curt G., Clendeninn N., Chabner B. The pharmacology and clinical use of methotrexate. N. Eng. J. Med, 1983;309:1094-1104.
5. 5. .Dutz JP, Ho VC. Immunosuppressive agents in dermatology. Dermatol Clin. 1998;16[2]:235-251.